Does Blue Cross Blue Shield cover GLP-1 medications?
commercial
Blue Cross Blue Shield is a federation of 33 independent companies covering ~115 million Americans. Each Blue plan sets its own formulary.
What Blue Cross Blue Shield specifically requires
- Blue Cross Blue Shield of Massachusetts ended GLP-1 coverage except for type 2 diabetes at plan renewals starting January 1, 2026. Employers with more than 100 employees may keep coverage; smaller groups and direct-pay members cannot. Blue Cross Blue Shield of Massachusetts: GLP-1 coverage update, Effective Jan 1, 2026
- Blue Cross Blue Shield of Michigan and Blue Care Network stopped covering Saxenda, Wegovy and Zepbound for weight loss for fully insured large groups from January 1, 2025 or the group's 2025 renewal date. Blue Cross Blue Shield of Michigan provider alert: 2025 GLP-1 coverage change, Sep 27, 2024
- FEP Blue (federal employees) covers Zepbound with prior approval, and requires an inadequate response or intolerance to at least two oral weight-loss drugs first (policy 5.99.031). FEP Blue policy 5.99.031: Zepbound, Effective Jul 1, 2026
- FEP Blue's Zepbound criteria also require participation in a comprehensive weight management program, such as Teladoc; the first approval lasts 6 months and renewals last 12 months. FEP Blue policy 5.99.031: Zepbound, Effective Jul 1, 2026
BCBS coverage by drug
- Varies by planWegovysemaglutide
Each Blue Cross Blue Shield company sets its own coverage, and several have dropped weight-loss GLP-1s. Blue Cross Blue Shield of Massachusetts ended coverage at plan renewals from January 1, 2026 (employers with more than 100 employees may keep it), and Blue Cross Blue Shield of Michigan ended it for fully insured large groups from January 1, 2025. Check your own Blue plan's drug list.
- Varies by planZepboundtirzepatide
Zepbound coverage depends on your Blue plan. Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan both ended weight-loss GLP-1 coverage for many members. The federal employee plan, FEP Blue, covers Zepbound with prior approval under policy 5.99.031, which requires trying two oral weight-loss drugs first.
- Covered (prior auth required)Ozempicsemaglutide
When Blue Cross Blue Shield of Massachusetts ended weight-loss GLP-1 coverage in 2026, it kept coverage of GLP-1s approved for type 2 diabetes, including Ozempic, Mounjaro and Trulicity. They still require prior authorization that includes a documented diabetes diagnosis. Other Blue plans set their own rules.
- Covered (prior auth required)Mounjarotirzepatide
Blue Cross Blue Shield of Massachusetts continues to cover Mounjaro for type 2 diabetes with prior authorization that includes a documented diabetes diagnosis, after ending weight-loss GLP-1 coverage in 2026. Other Blue plans set their own rules.
- Limited coverageSaxendaliraglutide
Blue Cross Blue Shield of Michigan named Saxenda among the weight-loss GLP-1s it stopped covering for fully insured large groups from January 1, 2025, and Blue Cross Blue Shield of Massachusetts ended GLP-1 coverage for weight loss from January 1, 2026. Other Blue plans set their own rules.
- CoveredZoloftsertraline
Generic sertraline is a widely used generic antidepressant. Check your plan's drug list for its tier and copay.
- CoveredLexaproescitalopram
Generic escitalopram is a widely used generic antidepressant. Check your plan's drug list for its tier and copay.
- Limited coverageViagrasildenafil
Many plans limit or exclude drugs for erectile dysfunction. Check your plan's drug list for quantity limits and prior authorization; cash-pay generic sildenafil can cost less than a copay.
- Limited coverageCialistadalafil
Plans may treat tadalafil for benign prostatic hyperplasia (BPH) differently from tadalafil for erectile dysfunction. Check your plan's drug list for the use you are prescribed.
- Not coveredPropeciafinasteride
Plans that cover finasteride usually do so for benign prostatic hyperplasia (5 mg). The 1 mg dose for hair loss is often treated as cosmetic. Check your plan's drug list.
Reminder: coverage varies by plan
Blue Cross Blue Shield offers many plan designs. The same medication can be covered under one BCBS plan and excluded from another. Always confirm with your specific plan's formulary or call the number on your insurance card before assuming coverage.
Frequently asked
Does Blue Cross Blue Shield cover GLP-1 medications for weight loss?+
Each Blue plan sets its own drug coverage. Blue Cross Blue Shield of Massachusetts ended weight-loss GLP-1 coverage at plan renewals from January 1, 2026, and Blue Cross Blue Shield of Michigan ended it for fully insured large groups from January 1, 2025. Both kept coverage of GLP-1s for type 2 diabetes. GLP-1 coverage at BCBS varies plan by plan. For Wegovy and Zepbound (weight-loss indications), expect prior authorization at minimum, with formal documentation of BMI and previous lifestyle interventions. For Ozempic and Mounjaro (type 2 diabetes), coverage is generally easier when prescribed for diabetes.
Does Blue Cross Blue Shield require a prior authorization for Wegovy or Zepbound?+
Yes, prior authorization (PA) is the norm for weight-loss GLP-1s across BCBS plans. A PA typically requires documented BMI ≥30 (or ≥27 with a comorbidity), prior attempts at structured weight loss, and sometimes step-therapy through cheaper alternatives. Your prescriber's office files the PA.
How do I check if my specific BCBS plan covers a drug?+
Three steps: (1) Log into your BCBS member portal and search the drug formulary by name. (2) Call the member services number on your insurance card. (3) Ask your prescriber to submit a benefits inquiry. Plan designs differ widely within Blue Cross Blue Shield — what's covered for one member may not be covered for another.
What if BCBS denies my GLP-1 prior authorization?+
Three options: (1) Appeal — most plans grant an appeal that adds physician peer-to-peer review; your prescriber can request this. (2) Switch indication if clinically appropriate (e.g., if you have prediabetes and BMI ≥30, your physician may have different coverage paths). (3) Use manufacturer direct-pay (NovoCare, LillyDirect) which doesn't depend on insurance approval.
Are compounded GLP-1s covered by BCBS?+
Generally no. Most insurance plans, including BCBS, do not cover compounded semaglutide or tirzepatide regardless of pharmacy. As of 2026, the FDA is winding down large-scale compounding, so coverage questions are increasingly moot — most patients are transitioning to branded GLP-1s or manufacturer direct-pay programs.